ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N02BE01 | B | Paracetamol - 300mg | 11232 | 145621/1 | DOLIPRANE | 300mg | 10 | Suppository | Rectal | Mersaco | Opella Healthcare International SAS | France | 143,791 L.L | 23.08 | A1 | Opella Healthcare France SAS | France | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N02BE01 | B | Paracetamol - 300mg | 1772 | 973886/02 | DOLIPRANE | 300mg | 10 | Suppository | Rectal | Mersaco | Sanofi Winthrop Industrie | France | 143,791 L.L | 23.08 | A1 | Sanofi Aventis | France | 2/5/2024 | 0 |
N02BE01 | B | Paracetamol - 300mg | 9981 | 2119/1 | EFFERALGAN 300MG PAEDIATRIC | 300mg | 10 | Suppository | Rectal | Pacific pharma | UPSA SAS, Agen | France | 157,230 L.L | 23.08 | A1 | UPSA SAS | France | 2/5/2024 | 0 |